NATCO Pharma Limited
NSE:NATCOPHARM.NS
1407.15 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 39,988 | 27,071 | 19,049 | 16,903 | 18,878 | 20,618 | 21,567 | 20,399 | 11,248.471 | 8,186.333 | 7,307.587 | 6,500.58 | 5,200.464 | 4,373.839 | 4,307.531 | 4,381.985 | 3,277.373 | 2,415.232 | 1,680.913 | 1,544.032 |
| Cost of Revenue
| 14,284 | 6,273 | 6,815 | 6,079 | 5,100 | 4,619 | 5,089 | 6,940 | 3,931.294 | 2,832.477 | 2,757.863 | 2,756.056 | 2,377.598 | 789.265 | 813.278 | 967.464 | 898.329 | 856.125 | 1,325.423 | 1,155.789 |
| Gross Profit
| 25,704 | 20,798 | 12,234 | 10,824 | 13,778 | 15,999 | 16,478 | 13,459 | 7,317.177 | 5,353.856 | 4,549.723 | 3,744.524 | 2,822.865 | 3,584.575 | 3,494.253 | 3,414.522 | 2,379.043 | 1,559.108 | 355.49 | 388.243 |
| Gross Profit Ratio
| 0.643 | 0.768 | 0.642 | 0.64 | 0.73 | 0.776 | 0.764 | 0.66 | 0.651 | 0.654 | 0.623 | 0.576 | 0.543 | 0.82 | 0.811 | 0.779 | 0.726 | 0.646 | 0.211 | 0.251 |
| Reseach & Development Expenses
| 1,211 | 902 | 1,769 | 1,473 | 633 | 724 | 462 | 460 | 150.702 | 126.085 | 142.852 | 146.336 | 84.271 | 110.462 | 77.886 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 1,069 | 818 | 565 | 587 | 514 | 381 | 380 | 252.228 | 241.465 | 266.438 | 133.627 | 506.698 | 397.774 | 261.421 | 525.425 | 413.847 | 330.725 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 961 | 437 | 344 | 981 | 1,372 | 1,369 | 1,432 | 1,126.775 | 373.582 | 261.604 | 148.207 | 225.275 | 132.42 | 125.581 | 55.887 | 43.198 | 32.861 | 0 | 0 |
| SG&A
| 10,058 | 2,030 | 1,255 | 909 | 1,568 | 1,886 | 1,750 | 1,812 | 1,379.002 | 615.047 | 528.042 | 281.834 | 731.973 | 530.194 | 387.001 | 581.312 | 457.045 | 363.586 | 0 | 0 |
| Other Expenses
| 1,281 | 1,046 | 40 | 110 | 40 | 20 | 16 | 11 | 18.15 | 14.192 | 14.145 | 3.996 | 5.006 | 2,050.803 | -3.42 | -35.766 | -11.049 | -18.094 | 116.576 | 71.293 |
| Operating Expenses
| 10,058 | 13,080 | 10,810 | 5,814 | 8,866 | 8,819 | 7,723 | 6,904 | 4,954.302 | 3,646.164 | 3,043.865 | 2,425.329 | 1,885.308 | 2,691.458 | 2,636.186 | 2,653.571 | 1,715.017 | 1,055.84 | 116.576 | 71.293 |
| Operating Income
| 15,646 | 8,764 | 2,199 | 5,010 | 4,912 | 7,180 | 8,755 | 6,555 | 2,362.876 | 1,707.692 | 1,505.858 | 1,319.195 | 937.557 | 893.116 | 858.067 | 760.951 | 664.026 | 503.267 | 238.913 | 316.95 |
| Operating Income Ratio
| 0.391 | 0.324 | 0.115 | 0.296 | 0.26 | 0.348 | 0.406 | 0.321 | 0.21 | 0.209 | 0.206 | 0.203 | 0.18 | 0.204 | 0.199 | 0.174 | 0.203 | 0.208 | 0.142 | 0.205 |
| Total Other Income Expenses Net
| 1,089 | -145 | -177 | 786 | 775 | 1,067 | 117 | -311 | -296.637 | -365.52 | -216.09 | -296.002 | -142.139 | -241.884 | -226.51 | -194.543 | -110.851 | -105.354 | 33.254 | -309.453 |
| Income Before Tax
| 16,735 | 8,619 | 2,022 | 5,796 | 5,687 | 8,247 | 8,872 | 6,244 | 2,066.238 | 1,342.172 | 1,289.768 | 1,023.193 | 795.418 | 651.232 | 631.557 | 566.408 | 553.175 | 397.913 | 272.167 | 7.497 |
| Income Before Tax Ratio
| 0.419 | 0.318 | 0.106 | 0.343 | 0.301 | 0.4 | 0.411 | 0.306 | 0.184 | 0.164 | 0.176 | 0.157 | 0.153 | 0.149 | 0.147 | 0.129 | 0.169 | 0.165 | 0.162 | 0.005 |
| Income Tax Expense
| 2,852 | 1,466 | 322 | 1,372 | 1,106 | 1,823 | 1,920 | 1,395 | 527.978 | 39.502 | 308.7 | 364.364 | 210.748 | 132.113 | 136.612 | 112.896 | 148.038 | 93.287 | 34.233 | -8.071 |
| Net Income
| 13,883 | 7,153 | 1,700 | 4,409 | 4,608 | 6,444 | 6,962 | 4,860 | 1,551.754 | 1,346.158 | 1,027.343 | 718.691 | 596.083 | 535.111 | 487.181 | 439.719 | 405.137 | 304.626 | 237.934 | 15.568 |
| Net Income Ratio
| 0.347 | 0.264 | 0.089 | 0.261 | 0.244 | 0.313 | 0.323 | 0.238 | 0.138 | 0.164 | 0.141 | 0.111 | 0.115 | 0.122 | 0.113 | 0.1 | 0.124 | 0.126 | 0.142 | 0.01 |
| EPS
| 77.34 | 39.18 | 9.32 | 24.2 | 25.33 | 34.98 | 39.26 | 27.89 | 9.14 | 8.13 | 6.43 | 4.6 | 4.11 | 3.8 | 3.46 | 3.14 | 2.89 | 2.2 | 1.75 | 0.12 |
| EPS Diluted
| 77.34 | 39.18 | 9.32 | 24.16 | 25.26 | 34.87 | 39.13 | 27.87 | 9.11 | 8.13 | 6.43 | 4.58 | 4.11 | 3.8 | 3.46 | 3.14 | 2.89 | 2.2 | 1.75 | 0.12 |
| EBITDA
| 17,514 | 10,402 | 3,340 | 6,850 | 6,754 | 9,104 | 9,696 | 7,211 | 2,885.425 | 2,245.901 | 1,937.007 | 1,606.383 | 1,126.517 | 1,151.837 | 1,145.735 | 922.352 | 768.748 | 611.55 | 433.259 | 425.575 |
| EBITDA Ratio
| 0.438 | 0.384 | 0.175 | 0.405 | 0.358 | 0.442 | 0.45 | 0.353 | 0.257 | 0.274 | 0.265 | 0.247 | 0.217 | 0.263 | 0.266 | 0.21 | 0.235 | 0.253 | 0.258 | 0.276 |